Name | Title | Contact Details |
---|
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.
Smith & Nephew is a Andover, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
KPI Ultrasound is a Riverside, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Swissray International is a East Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Second Sight ® Medical Products, Inc., located in Sylmar, California, was founded in 1998 to create a retinal prosthesis to provide sight to patients blinded from outer retinal degenerations, such as Retinitis Pigmentosa.